Your browser doesn't support javascript.
loading
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma.
McGregor, Bradley; Geynisman, Daniel M; Burotto, Mauricio; Porta, Camillo; Suarez, Cristina; Bourlon, Maria T; Del Tejo, Viviana; Du, Ella X; Yang, Xiaoran; Sendhil, Selvam R; Betts, Keith A; Huo, Stephen.
  • McGregor B; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Geynisman DM; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile.
  • Porta C; University of Bari "A. Moro," and Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy.
  • Suarez C; Vall d´Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d´Hebron, Vall d´Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Bourlon MT; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Del Tejo V; Bristol Myers Squibb, Princeton, NJ, USA.
  • Du EX; Analysis Group, Inc., Los Angeles, CA, USA.
  • Yang X; Analysis Group, Inc., Los Angeles, CA, USA.
  • Sendhil SR; Analysis Group, Inc., Los Angeles, CA, USA.
  • Betts KA; Analysis Group, Inc., Los Angeles, CA, USA.
  • Huo S; Bristol Myers Squibb, Princeton, NJ, USA.
Oncologist ; 28(1): 72-79, 2023 01 18.
Article en En | MEDLINE | ID: mdl-36124890
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Health_economic_evaluation Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Health_economic_evaluation Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article